Morphological features of IFN-γ–stimulated mesenchymal stromal cells predict overall immunosuppressive capacity
Authors:
- 10 March 2017
- journal article
- research article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 114 (13) , E2598-E2607
Abstract
Significance: Substantial evidence exists demonstrating the immunosuppressive function of mesenchymal stromal cells (MSCs), but inconsistent clinical results suggest that better understanding of MSC-mediated immunosuppression and identification of features predictive of immunosuppressive capacity would advance MSC-based therapeutics. In this work, we present a robust analytical approach to quantify the immunosuppressive capacity of MSCs by integrating high-dimensional flow cytometry data from multiple experimental conditions into a single measure of immunosuppressive capacity. Additionally, we identified morphological features of MSCs that predicted immunosuppressive capacity, as well as the magnitude of IFN-γ–mediated immunosuppression enhancement. These improved methods of MSC characterization could be used to identify MSC preparations with desired immunosuppressive capacity, as well as screen for pretreatments that enhance their immunosuppressive function.Keywords
Funding Information
- HHS | U.S. Food and Drug Administration (na)
- HHS | U.S. Food and Drug Administration (na)
This publication has 58 references indexed in Scilit:
- Morphology-Based Prediction of Osteogenic Differentiation Potential of Human Mesenchymal Stem CellsPLOS ONE, 2013
- IL-2 family cytokines: new insights into the complex roles of IL-2 as a broad regulator of T helper cell differentiationCurrent Opinion in Immunology, 2011
- Discrepancy between the in vitro and in vivoeffects of murine mesenchymal stem cells on T-cell proliferation and collagen-induced arthritisArthritis Research & Therapy, 2010
- Cytoskeleton-based forecasting of stem cell lineage fatesProceedings of the National Academy of Sciences, 2009
- IFN‐γ activation of mesenchymal stem cells for treatment and prevention of graft versus host diseaseEuropean Journal of Immunology, 2008
- Physical plasticity of the nucleus in stem cell differentiationProceedings of the National Academy of Sciences, 2007
- Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statementCytotherapy, 2006
- Role for Interferon-γ in the Immunomodulatory Activity of Human Bone Marrow Mesenchymal Stem CellsStem Cells, 2005
- Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase–mediated tryptophan degradationBlood, 2004
- THE IFNγ RECEPTOR:A Paradigm for Cytokine Receptor SignalingAnnual Review of Immunology, 1997